首页|骨髓间充质干细胞条件培养基治疗大鼠糖尿病足溃疡的疗效及机制

骨髓间充质干细胞条件培养基治疗大鼠糖尿病足溃疡的疗效及机制

扫码查看
目的 探讨骨髓间充质干细胞条件培养基(mesenchymal stem cell-conditioned medium,MSC-CM)治疗大鼠糖尿病足溃疡(diabetic foot ulcer,DFU)的疗效与机制.方法 通过高脂饮食和腹腔注射STZ建立2型糖尿病(diabetes mellitus type 2,T2DM)SD大鼠模型,对大鼠后肢进行手术,制作DFU模型,大鼠分为正常对照(normal control,NC)组、糖尿病对照(diabetes mellitus control,DM-C)组、MSC-CM 组和间充质干细胞(mesenchymal stem cell,MSC)组共 4 组,每组各 6 只.MSC-CM 组在溃疡周围注射大鼠骨髓MSC-CM,MSC组给予大鼠骨髓MSC注射治疗,其他两组给予PBS注射治疗.治疗后,对创面部位皮肤愈合、再上皮化(通过HE染色检测皮肤颗粒层的厚度)、细胞增殖(通过免疫组化法检测ki-67)、血管生成(通过免疫荧光法检测CD31)、自噬(通过免疫荧光法和Western blot法检测LC3B,电镜观察自嗜溶酶体)和细胞焦亡(通过Western blot法检测IL-1β、NLRP3、caspase-1、GSDMD 和 GSDMD-N)进行评估.结果 治疗后,MSC-CM 组创面面积与 IL-1β、caspase-1、GSDMD、GSDMD-N均低于DM-C组;MSC-CM组皮肤颗粒层厚度、ki-67、CD31和LC3B均高于DM-C组.对DFUs大鼠注射MSC-CM能够加速创面愈合、促进细胞增殖和血管生成、增强细胞自噬和减少创面中的细胞焦亡.结论 MSC-CM可用于治疗大鼠DFU,加速伤口愈合过程,有望成为一种新的无细胞治疗方法.
Effect and Mechanism of Bone Marrow-derived Mesenchymal Stem Cell-conditioned Medium on Diabetic Foot Ulcers in Rats
Objective To explore the effect and mechanism of bone marrow-derived mesenchymal stem cell-conditioned medium(MSC-CM)on diabetic foot ulcer(DFU)in rats.Methods The model of diabetes mellitus type 2(T2DM)were induced by high fat diet and intraperitoneal injection of STZ in SD rats.DFU models were made by operation on hind limbs in diabetic rats.The rats were di-vided into four groups:normal control(NC)group,diabetes mellitus control(DM-C)group,MSC-CM group and mesenchymal stem cell(MSC)group,6 rats in each gruop.The MSC-CM group was injected with bone marrow-derived MSC-CM around ulcers.MSC group was injected with bone marrow-derived MSC.The other two groups were treated with injection of PBS.After the treatment,wound clousure,re-epithelialization(thickness of the stratum granulosums of the skin was detected by HE staining),cell proliferation(ki-67 was detected by immunohistochemistry),angiogenesis(CD31 was detected by immunofluorescence),autophagy(LC3B was detected by immunofluorescence and Western blot,autolysosome was observed by electron microscopy)and pyroptosis(IL-1 β,NLRP3,caspase-1,GSDMD and GSDMD-N were detected by Western blot)in ulers were evaluated.Results After the treatment,the wound area,IL-1β,caspase-1,GSDMD and GSDMD-N in MSC-CM group were lower than those in DM-C group.Thickness of the stratum gran-ulosums of the skin,ki-67,CD31 and LC3B in MSC-CM group were higher than those in DM-C group.The injection of MSC-CM to rats with DFU enhanced the wound healing process by accelerating wound closure,promoting cell proliferation and angiogenesis,enhan-cing cell autophagy and reducing cell pyroptosis in ulcers.Conclusion MSC-CM could be a novel cell-free therapeutic approach to treat rats with DFU accelerating the wound healing process.

Diabetic foot ulcerConditioned-mediumMesenchymal stem cellTherapy

许忆峰、吴雁翔、王红梅、高翠华、徐阳洋、闫杨

展开 >

110042 沈阳,北部战区空军医院内分泌科

110042 沈阳,北部战区空军医院血液科

糖尿病足溃疡 条件培养基 间充质干细胞 治疗

辽宁省自然科学基金

2020-MS-042

2024

医学研究杂志
中国医学科学院

医学研究杂志

CSTPCD
影响因子:0.702
ISSN:1673-548X
年,卷(期):2024.53(5)